NATALIE CURRY: Open Payments
NPI 1962144824 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,835 in 70 payments from 16 companies in 2025. Trend: 2023 $2,714 · 2024 $1,167 · 2025 $1,835
Food & beverage: $1,835
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $582 |
| Novo Nordisk Inc | 7 | $176 |
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Phathom Pharmaceuticals, Inc. | 4 | $162 |
| PFIZER INC. | 5 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $105 |
| Optinose US, Inc. | 1 | $98 |
| KYOWA KIRIN, INC. | 3 | $77 |
| Exact Sciences Corporation | 4 | $75 |
| Dexcom, Inc. | 2 | $63 |
Products named: MAVYRET, VOQUEZNA, QULIPTA, TEZSPIRE, NURTEC ODT, CREON, Xhance, UBRELVY.
Industry payments across CA — which companies pay providers there.
